Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CG+ Arrow JACC

K-Number: K161765 · 2016-09-06

Decision Date2016-09-06
Product CodeLJS
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

CG+ Arrow JACC is a medical device manufactured by Arrow International, Inc. (Subsidiary of Teleflex. It received FDA 510(k) clearance on 2016-09-06 under approval number K161765. The device is classified under product code LJS. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CG+ Arrow JACC?

CG+ Arrow JACC is a medical device that received FDA 510(k) clearance on 2016-09-06. It is manufactured by Arrow International, Inc. (Subsidiary of Teleflex. The 510(k) number is K161765.

When was CG+ Arrow JACC approved by the FDA?

CG+ Arrow JACC received FDA 510(k) clearance on 2016-09-06, under approval number K161765.

What company makes CG+ Arrow JACC?

CG+ Arrow JACC is manufactured by Arrow International, Inc. (Subsidiary of Teleflex.

What is the FDA product code for CG+ Arrow JACC?

The FDA product code for CG+ Arrow JACC is LJS.

Related Devices (Code: LJS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.